Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice

Sodium glucose cotransporter 2 inhibitors are expected to ameliorate the abnormalities associated with metabolic syndrome including non-alcoholic fatty liver disease. In this study, we investigated the effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on the development of non-al...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Obara, Koki, Shirakami, Yohei, Maruta, Akinori, Ideta, Takayasu, Miyazaki, Tsuneyuki, Kochi, Takahiro, Sakai, Hiroyasu, Tanaka, Takuji, Seishima, Mitsuru, Shimizu, Masahito
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5601657/
https://ncbi.nlm.nih.gov/pubmed/28938561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16874
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak